542 related articles for article (PubMed ID: 26310139)
1. Soluble epoxide hydrolase inhibitor 1-trifluoromethoxyphenyl-3- (1-propionylpiperidin-4-yl) urea attenuates bleomycin-induced pulmonary fibrosis in mice.
Zhou Y; Yang J; Sun GY; Liu T; Duan JX; Zhou HF; Lee KS; Hammock BD; Fang X; Jiang JX; Guan CX
Cell Tissue Res; 2016 Feb; 363(2):399-409. PubMed ID: 26310139
[TBL] [Abstract][Full Text] [Related]
2. Soluble epoxide hydrolase inhibitor AUDA decreases bleomycin-induced pulmonary toxicity in mice by inhibiting the p38/Smad3 pathways.
Dong XW; Jia YL; Ge LT; Jiang B; Jiang JX; Shen J; Jin YC; Guan Y; Sun Y; Xie QM
Toxicology; 2017 Aug; 389():31-41. PubMed ID: 28694203
[TBL] [Abstract][Full Text] [Related]
3. Soluble Epoxide Hydrolase Pharmacological Inhibition Decreases Alveolar Bone Loss by Modulating Host Inflammatory Response, RANK-Related Signaling, Endoplasmic Reticulum Stress, and Apoptosis.
Trindade-da-Silva CA; Bettaieb A; Napimoga MH; Lee KSS; Inceoglu B; Ueira-Vieira C; Bruun D; Goswami SK; Haj FG; Hammock BD
J Pharmacol Exp Ther; 2017 Jun; 361(3):408-416. PubMed ID: 28356494
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological Inhibition of Soluble Epoxide Hydrolase Ameliorates Chronic Ethanol-Induced Cardiac Fibrosis by Restoring Autophagic Flux.
Zhou C; Huang J; Li Q; Zhan C; He Y; Liu J; Wen Z; Wang DW
Alcohol Clin Exp Res; 2018 Oct; 42(10):1970-1978. PubMed ID: 30047995
[TBL] [Abstract][Full Text] [Related]
5. Soluble Epoxide Hydrolase Inhibitor Suppresses the Expression of Triggering Receptor Expressed on Myeloid Cells-1 by Inhibiting NF-kB Activation in Murine Macrophage.
Dong L; Zhou Y; Zhu ZQ; Liu T; Duan JX; Zhang J; Li P; Hammcok BD; Guan CX
Inflammation; 2017 Feb; 40(1):13-20. PubMed ID: 27696333
[TBL] [Abstract][Full Text] [Related]
6. The arachidonic acid metabolite 11,12-epoxyeicosatrienoic acid alleviates pulmonary fibrosis.
Kim HS; Moon SJ; Lee SE; Hwang GW; Yoo HJ; Song JW
Exp Mol Med; 2021 May; 53(5):864-874. PubMed ID: 33990688
[TBL] [Abstract][Full Text] [Related]
7. Epoxyeicosatrienoic Acids Inhibit the Activation of Murine Fibroblasts by Blocking the TGF-
Tao JH; Liu T; Zhang CY; Zu C; Yang HH; Liu YB; Yang JT; Zhou Y; Guan CX
Oxid Med Cell Longev; 2022; 2022():7265486. PubMed ID: 36275905
[TBL] [Abstract][Full Text] [Related]
8. Soluble epoxide hydrolase inhibitor promotes immunomodulation to inhibit bone resorption.
Napimoga MH; Rocha EP; Trindade-da-Silva CA; Demasi APD; Martinez EF; Macedo CG; Abdalla HB; Bettaieb A; Haj FG; Clemente-Napimoga JT; Inceoglu B; Hammock BD
J Periodontal Res; 2018 Oct; 53(5):743-749. PubMed ID: 29851077
[TBL] [Abstract][Full Text] [Related]
9. 1-Trifluoromethoxyphenyl-3-(1-propionylpiperidin-4-yl) Urea, a Selective and Potent Dual Inhibitor of Soluble Epoxide Hydrolase and p38 Kinase Intervenes in Alzheimer's Signaling in Human Nerve Cells.
Liang Z; Zhang B; Xu M; Morisseau C; Hwang SH; Hammock BD; Li QX
ACS Chem Neurosci; 2019 Sep; 10(9):4018-4030. PubMed ID: 31378059
[TBL] [Abstract][Full Text] [Related]
10. Soluble Epoxide Hydrolase Inhibition Protected against Angiotensin II-induced Adventitial Remodeling.
Zhou C; Huang J; Li Q; Nie J; Xu X; Wang DW
Sci Rep; 2017 Jul; 7(1):6926. PubMed ID: 28761179
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of soluble epoxide hydrolase attenuates hepatic fibrosis and endoplasmic reticulum stress induced by carbon tetrachloride in mice.
Harris TR; Bettaieb A; Kodani S; Dong H; Myers R; Chiamvimonvat N; Haj FG; Hammock BD
Toxicol Appl Pharmacol; 2015 Jul; 286(2):102-11. PubMed ID: 25827057
[TBL] [Abstract][Full Text] [Related]
12. Soluble epoxide hydrolase inhibition decreases reperfusion injury after focal cerebral ischemia.
Tu R; Armstrong J; Lee KSS; Hammock BD; Sapirstein A; Koehler RC
Sci Rep; 2018 Mar; 8(1):5279. PubMed ID: 29588470
[TBL] [Abstract][Full Text] [Related]
13. Soluble epoxide hydrolase inhibitor attenuates BBB disruption and neuroinflammation after intracerebral hemorrhage in mice.
Tian Y; Yuan X; Wang Y; Wu Q; Fang Y; Zhu Z; Song G; Xu L; Wang W; Xie M
Neurochem Int; 2021 Nov; 150():105197. PubMed ID: 34592333
[TBL] [Abstract][Full Text] [Related]
14. Soluble Epoxide Hydrolase Inhibition Attenuates MPTP-Induced Neurotoxicity in the Nigrostriatal Dopaminergic System: Involvement of α-Synuclein Aggregation and ER Stress.
Huang HJ; Wang YT; Lin HC; Lee YH; Lin AM
Mol Neurobiol; 2018 Jan; 55(1):138-144. PubMed ID: 28822080
[TBL] [Abstract][Full Text] [Related]
15. A Soluble Epoxide Hydrolase Inhibitor, 1-TrifluoromethoxyPhenyl-3-(1-Propionylpiperidin-4-yl) Urea, Ameliorates Experimental Autoimmune Encephalomyelitis.
Jonnalagadda D; Wan D; Chun J; Hammock BD; Kihara Y
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33925035
[TBL] [Abstract][Full Text] [Related]
16. Soluble Epoxide Hydrolase Inhibitor Attenuates Lipopolysaccharide-Induced Acute Lung Injury and Improves Survival in Mice.
Zhou Y; Liu T; Duan JX; Li P; Sun GY; Liu YP; Zhang J; Dong L; Lee KSS; Hammock BD; Jiang JX; Guan CX
Shock; 2017 May; 47(5):638-645. PubMed ID: 27753791
[TBL] [Abstract][Full Text] [Related]
17. Soluble Epoxide Hydrolase Pharmacological Inhibition Ameliorates Experimental Acute Pancreatitis in Mice.
Bettaieb A; Chahed S; Bachaalany S; Griffey S; Hammock BD; Haj FG
Mol Pharmacol; 2015 Aug; 88(2):281-90. PubMed ID: 25993999
[TBL] [Abstract][Full Text] [Related]
18. Peripheral soluble epoxide hydrolase inhibition reduces hypernociception and inflammation in albumin-induced arthritis in temporomandibular joint of rats.
Teixeira JM; Abdalla HB; Basting RT; Hammock BD; Napimoga MH; Clemente-Napimoga JT
Int Immunopharmacol; 2020 Oct; 87():106841. PubMed ID: 32736189
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological inhibition of soluble epoxide hydrolase prevents renal interstitial fibrogenesis in obstructive nephropathy.
Kim J; Yoon SP; Toews ML; Imig JD; Hwang SH; Hammock BD; Padanilam BJ
Am J Physiol Renal Physiol; 2015 Jan; 308(2):F131-9. PubMed ID: 25377915
[TBL] [Abstract][Full Text] [Related]
20. Soluble epoxide hydrolase inhibitor, TPPU, increases regulatory T cells pathway in an arthritis model.
Trindade-da-Silva CA; Clemente-Napimoga JT; Abdalla HB; Rosa SM; Ueira-Vieira C; Morisseau C; Verri WA; Montalli VAM; Hammock BD; Napimoga MH
FASEB J; 2020 Jul; 34(7):9074-9086. PubMed ID: 32400048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]